- Home
- SCPH vs CYBN Comparison
SCPH vs CYBN Comparison
Compare SCPH & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- CYBN
- Stock Information
- Founded
- SCPH 2013
- CYBN 2019
- Country
- SCPH United States
- CYBN Canada
- Employees
- SCPH N/A
- CYBN N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- SCPH Health Care
- CYBN Health Care
- Exchange
- SCPH Nasdaq
- CYBN Nasdaq
- Market Cap
- SCPH 173.6M
- CYBN 176.0M
- IPO Year
- SCPH 2017
- CYBN N/A
- Fundamental
- Price
- SCPH $4.85
- CYBN $7.11
- Analyst Decision
- SCPH Strong Buy
- CYBN Strong Buy
- Analyst Count
- SCPH 3
- CYBN 3
- Target Price
- SCPH $14.00
- CYBN $85.00
- AVG Volume (30 Days)
- SCPH 322.0K
- CYBN 351.0K
- Earning Date
- SCPH 08-07-2025
- CYBN 08-13-2025
- Dividend Yield
- SCPH N/A
- CYBN N/A
- EPS Growth
- SCPH N/A
- CYBN N/A
- EPS
- SCPH N/A
- CYBN N/A
- Revenue
- SCPH $49,969,000.00
- CYBN N/A
- Revenue This Year
- SCPH $108.95
- CYBN N/A
- Revenue Next Year
- SCPH $73.83
- CYBN N/A
- P/E Ratio
- SCPH N/A
- CYBN N/A
- Revenue Growth
- SCPH 107.79
- CYBN N/A
- 52 Week Low
- SCPH $1.94
- CYBN $4.81
- 52 Week High
- SCPH $6.28
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- SCPH 51.56
- CYBN 45.43
- Support Level
- SCPH $4.33
- CYBN $6.36
- Resistance Level
- SCPH $4.82
- CYBN $7.75
- Average True Range (ATR)
- SCPH 0.35
- CYBN 0.34
- MACD
- SCPH -0.07
- CYBN -0.04
- Stochastic Oscillator
- SCPH 49.55
- CYBN 51.95
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.